Health ❯ Pharmaceuticals

Drug Development

Clinical Trials Weight Loss Drugs Clinical Research Regulatory Affairs Obesity Treatments Oncology Cancer Drugs Market Competition Regulatory Approval Cancer Treatment

Novo Nordisk Strikes Deal With Hims & Hers to Sell Wegovy and Ozempic, Drops Lawsuit

The tie-up redirects Hims’ weight-loss business toward FDA-approved drugs at Novo’s self-pay prices.

EMA Backs Single-Dose Acoziborole for Gambiense Sleeping Sickness Outside EU

Novo Nordisk Licenses Vivtex Platform in $2.1 Billion Push for Oral Obesity and Diabetes Drugs

Japan Panel Clears iPS Cell Therapies for Heart Failure and Parkinson’s

Exercise-Linked Liver Enzyme Restores Brain Barrier and Memory in Aging Mice

Insmed Sets $1 Billion 2026 Brinsupri Target After Strong First Full Quarter

WHO-Backed Reviews Affirm GLP-1 Weight-Loss Gains as Clinicians Flag Safety and Nutrition Gaps

NCI Pursues Preclinical Test of Ivermectin’s Anti-Cancer Activity

EU Orders Meta to Open WhatsApp to Rival AI Chatbots

Lilly and Innovent Forge Territory-Split Cancer and Immunology Alliance

India Notifies Risk-Based Overhaul of Drug R&D Rules

Vistagen Hit With Securities Class Actions After Phase 3 Miss as Investors Face March 16 Deadline

Vistagen Faces Federal Securities Class Action After Fasedienol Phase 3 Failure

EMA and FDA Unveil Joint Principles for AI in Drug Development

Skye Bioscience Investors Face Friday Deadline in Securities Class Action Over Nimacimab Disclosures

Amgen Reports Year-Long Weight-Loss Maintenance With Monthly or Quarterly MariTide Dosing

Nvidia, Eli Lilly Commit Up to $1 Billion for Bay Area AI Drug Discovery Lab

GSK and Ionis Report Phase 3 Success for Hepatitis B Drug, Plan Q1 Filings

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

Variant Bio Launches Agentic AI Genomics Platform as It Secures Boehringer Ingelheim Kidney-Disease Deal